BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6140271)

  • 1. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.
    Taborsky GJ; Ensinck JW
    J Clin Invest; 1984 Jan; 73(1):216-23. PubMed ID: 6140271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 2). Effects on basal release of somatostatin and pancreatic polypeptide.
    Ahrén B; Veith RC; Paquette TL; Taborsky GJ
    Endocrinology; 1987 Jul; 121(1):332-9. PubMed ID: 2885175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin gene-related peptide: a potent and selective stimulator of gastrointestinal somatostatin secretion.
    Dunning BE; Taborsky GJ
    Endocrinology; 1987 May; 120(5):1774-81. PubMed ID: 2882997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal gastropancreatic modulations for the release of somatostatin-like immunoreactivity, glucagon, and insulin in the rat.
    Marre M; Miller J; Helman AM; Assan R
    Diabetes; 1983 Aug; 32(8):768-73. PubMed ID: 6347773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galanin release during pancreatic nerve stimulation is sufficient to influence islet function.
    Dunning BE; Taborsky GJ
    Am J Physiol; 1989 Jan; 256(1 Pt 1):E191-8. PubMed ID: 2463765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.
    Berelowitz M; Kronheim S; Pimstone B; Shapiro B
    J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin-28 does not regulate islet function in the dog.
    Klaff LJ; Dunning BE; Taborsky GJ
    Endocrinology; 1988 Dec; 123(6):2668-74. PubMed ID: 2904358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs.
    Wasada T; Howard B; Dobbs RE; Unger RH
    J Clin Invest; 1980 Sep; 66(3):511-6. PubMed ID: 6105166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
    Wasada T; Dobbs RE; Harris V; Unger RH
    Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs.
    Schusdziarra V; Zyznar E; Rouiller D; Harris V; Unger RH
    Endocrinology; 1980 Nov; 107(5):1572-6. PubMed ID: 6107241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.
    Schusdziarra V; Harris V; Conlon JM; Arimura A; Unger R
    J Clin Invest; 1978 Sep; 62(3):509-18. PubMed ID: 690183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing actions of glucagon and insulin on splanchnic d cell function.
    Kawai K; Unger RH
    J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects.
    Schusdziarra V; Lawecki J; Ditschuneit HH; Lukas B; Maier V; Pfeiffer EF
    Diabetes; 1985 Jun; 34(6):595-601. PubMed ID: 2861127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origin of peripheral venous hypersomatostatinemia in alloxan-diabetic dogs.
    Schusdziarra V; Rouiller D; Harris V; Unger RH
    Endocrinology; 1981 Oct; 109(4):1107-16. PubMed ID: 6116595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
    Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
    J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acetylcholine on the release of pancreatic and gastric somatostatin-like immunoreactivity in normal, chemically sympathectomized and indomethacin-treated dogs.
    Schusdziarra V; Stapelfeldt W; Klier M; Pfeiffer EF
    Hepatogastroenterology; 1982 Aug; 29(4):153-6. PubMed ID: 6127302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of E coli endotoxin on pancreatic hormones and blood flow.
    Spitzer JJ; Ferguson JL; Hirsch HJ; Loo S; Gabbay KH
    Circ Shock; 1980; 7(4):353-60. PubMed ID: 6112073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin-like immunoreactivity (SLI) in pancreatic and intestinal tissues of the duck. A possible origin for the portal circulating SLI.
    Di Scala-Guenot D; Strosser MT; Mialhe P
    Horm Metab Res; 1985 Nov; 17(11):566-71. PubMed ID: 2867025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
    Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E
    J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.